Fluctuations of Histone Chemical Modifications in Breast, Prostate, and Colorectal Cancer: An Implication of Phytochemicals as Defenders of Chromatin Equilibrium
Authors:
- Marek SamecMSMarek Samec
- Alena LiskovaALAlena Liskova
- Lenka KoklesovaLKLenka Koklesova
- Veronika MestanovaVMVeronika Mestanova
- Maria FranekovaMFMaria Franekova
- Monika KassayovaMKMonika Kassayova
- Bianka BojkovaBBBianka Bojkova
- Sona UramovaSUSona Uramova
- Pavol ZuborPavol Zubor
- Katarina JanikovaKJKatarina Janikova
- Jan DankoJDJan Danko
- Samson Mathews SamuelSSSamson Mathews Samuel
Open Access
- 5 December 2019
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 9 (12) , 829
Abstract
Natural substances of plant origin exert health beneficiary efficacy due to the content of various phytochemicals. Significant anticancer abilities of natural compounds are mediated via various processes such as regulation of a cell’s epigenome. The potential antineoplastic activity of plant natural substances mediated by their action on posttranslational histone modifications (PHMs) is currently a highly evaluated area of cancer research. PHMs play an important role in maintaining chromatin structure and regulating gene expression. Aberrations in PHMs are directly linked to the process of carcinogenesis in cancer such as breast (BC), prostate (PC), and colorectal (CRC) cancer, common malignant diseases in terms of incidence and mortality among both men and women. This review summarizes the effects of plant phytochemicals (isolated or mixtures) on cancer-associated PHMs (mainly modulation of acetylation and methylation) resulting in alterations of chromatin structure that are related to the regulation of transcription activity of specific oncogenes, which are crucial in the development of BC, PC, and CRC. Significant effectiveness of natural compounds in the modulation of aberrant PHMs were confirmed by a number of in vitro or in vivo studies in preclinical cancer research. However, evidence concerning PHMs-modulating abilities of plant-based natural substances in clinical trials is insufficient.Keywords
Funding Information
- The Scientific Grant Agency of the Ministry of Education of the Slovak Republic (1/0136/19)
- the Slovak Research and Development Agency (APVV-16-0021)
This publication has 185 references indexed in Scilit:
- Phosphorylation of histone H3 serine 28 modulates RNA polymerase III-dependent transcriptionOncogene, 2011
- Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cellsMolecular Nutrition & Food Research, 2011
- Regulation of chromatin by histone modificationsCell Research, 2011
- Reciprocal epigenetic modification of histone H2B occurs in chromatin during apoptosis in vitro and in vivoCell Death & Differentiation, 2010
- BBAP Monoubiquitylates Histone H4 at Lysine 91 and Selectively Modulates the DNA Damage ResponseMolecular Cell, 2009
- Global Histone H4 Acetylation and HDAC2 Expression in Colon Adenoma and CarcinomaDigestive Diseases and Sciences, 2008
- Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancersMolecular Carcinogenesis, 2008
- Histone modifications as markers of cancer prognosis: a cellular viewBritish Journal of Cancer, 2007
- Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basisPharmacological Research, 2007
- Chromosomal Protein HMGN1 Modulates the Phosphorylation of Serine 1 in Histone H2ABiochemistry, 2006